Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/19/1999US5968733 Mycobacteriophages and uses thereof
10/19/1999US5968526 Mixing blood sample with peptide isolated from dust mite allergen protein to determine amount of binding which will indicate degree of sensitivity
10/19/1999US5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor
10/19/1999US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999US5968522 Dna and antibiodies directed against polypeptides
10/19/1999US5968521 Conjugate vaccine for group B Streptococcus
10/19/1999US5968514 Polypeptides and proteins for immunology
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968510 CTLA4 receptor and uses thereof
10/19/1999US5968502 Genetic engineering of proteins in cells
10/19/1999US5968501 Genetically engineering, transformation
10/19/1999US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/19/1999CA2119974C Human cell adhesion molecule and nucleic acid sequences
10/19/1999CA1340796C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections, and methods for identification of bacteria
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/17/1999CA2268457A1 Mammalian rad1 genes, polypeptides and methods of use
10/16/1999CA2269396A1 Bioactive peptides, uses thereof and process for the production of same
10/16/1999CA2269192A1 Novel g protein coupled receptor
10/14/1999WO1999051988A1 Method to detect biologically active, allergen-specific immunoglobulins
10/14/1999WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999WO1999051779A2 Glaucoma therapeutics and diagnostics
10/14/1999WO1999051762A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051756A2 Promoter and constructions for expression of recombinant proteins in filamentous fungi
10/14/1999WO1999051754A1 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
10/14/1999WO1999051753A1 Compositions and methods for protein secretion
10/14/1999WO1999051750A1 Medicaments for inducing cytotoxic t-cells
10/14/1999WO1999051749A2 Recombinant potyvirus construct and use thereof
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051746A1 Improved yeast strain
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051740A2 Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
10/14/1999WO1999051739A1 Protein variant of the net1 locus
10/14/1999WO1999051738A1 Human gap junction protein beta-4
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051736A1 Neuron regulatory factor comprising a small peptide for promoting neuron survival
10/14/1999WO1999051733A2 Enterotoxin-deficient bacillus
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051730A2 Mammalian gene encoding tolloid-like protein
10/14/1999WO1999051728A2 Control of floral induction in plants and uses therefor
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051725A2 Assay for the diagnosis of schizophrenia based on a new peptide
10/14/1999WO1999051721A1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
10/14/1999WO1999051643A1 Mutagenized il13-based chimeric molecules
10/14/1999WO1999051641A1 G-protein fusion receptors and chimeric gabab receptors
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999WO1999051638A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS
10/14/1999WO1999051637A1 Mammalian selenoprotein differentially expressed in tumor cells
10/14/1999WO1999051636A2 Gaba b receptor
10/14/1999WO1999051635A1 Transcription factors and their use
10/14/1999WO1999051634A1 Human gap junction protein beta-3
10/14/1999WO1999051633A1 Proteins having immunomodulatory activity and remedies for immunological diseases
10/14/1999WO1999051632A1 Circularly permuted biotin binding proteins
10/14/1999WO1999051631A1 A protein region responsible of binding to epithelial cell types and a dna sequence encoding said region
10/14/1999WO1999051630A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination
10/14/1999WO1999051629A2 New compounds for dna-transfection
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051625A2 Peptides causing formation of compact structures
10/14/1999WO1999051624A1 Reagents and methods for inhibiting furin protease activity
10/14/1999WO1999051622A1 Avian il-15 nucleotides and polypeptides, and methods of immunizing poultry using avian il-15
10/14/1999WO1999051620A1 Libraries of expressible gene sequences
10/14/1999WO1999051275A2 Mesenchymal stem cells as immunosuppressants
10/14/1999WO1999051270A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999WO1999051268A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999WO1999051267A1 Hiv-specific cytotoxic t-cell responses
10/14/1999WO1999051266A2 Derivatives of pneumococcal choline binding proteins for vaccines
10/14/1999WO1999051264A2 Leishmania cysteine proteinases
10/14/1999WO1999051258A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE
10/14/1999WO1999051254A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051187A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999WO1999043819B1 Family of maize pr-1 genes and promoters
10/14/1999WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999WO1999043705A8 N-terminally truncated glp-1 derivatives
10/14/1999WO1999043701A3 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them
10/14/1999WO1999043361A8 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999WO1999042075A3 Antibodies against human cd40
10/14/1999WO1999041399A9 Methods for purified aav vector production
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999WO1999037812A9 Single nucleotide polymorphisms of the uncoupling protein 2 (ucp2) gene
10/14/1999WO1999037803A3 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
10/14/1999WO1999037783A9 Live vaccine against brucellosis
10/14/1999WO1999037759A3 Live attenuated salmonella vaccine
10/14/1999WO1999037678A3 Antimicrobial peptides
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
10/14/1999WO1999036544A3 Neisseria meningitidis antigens
10/14/1999WO1999036094A9 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
10/14/1999WO1999033980A9 Members of tnf and tnfr families
10/14/1999WO1999028462A3 Polypeptides and nucleic acids encoding the same
10/14/1999WO1999028343A9 Hydrophobically-modified protein compositions and methods
1 ... 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 ... 2916